Navigation Links
Clinical Site Services, Industry Leader in Patient Enrollment Solutions, Announces New Website

GLEN BURNIE, Md., Aug. 28, 2012 /PRNewswire/ -- Clinical Site Services (CSS), a leader in patient enrollment solutions for the clinical research industry, is proud to announce the launch of its redesigned website,

"The first thing that visitors will notice is our individuality," shared CSS President Chris Trizna. "Yes, we are part of the patient recruitment industry, but where we differ is our focus:  our unique ability to make an impact on enrollment at each site."

This new website will provide enhanced details for sponsor companies, CROs and investigative sites who are seeking targeted data on CSS's offerings and experience, including case studies, a creative portfolio and a summary of services. Clients will be able to view real-time Facebook, Twitter, LinkedIn and YouTube feeds on the home page.

"Take a look at the case studies," added Trizna. "Clients can see where CSS's involvement positively impacts enrollment, not just responses, referrals or recruitment."

Future online offerings will include a blog centered around current patient recruitment trends and difficulties. CSS will also feature "Town Hall" style opportunities for discussion and review of specific patient recruitment challenges.

About Clinical Site Services

Clinical Site Services (CSS) is a site performance company that provides solutions to increase the enrollment potential for investigative sites. Through a proprietary, integrated process, CSS strives to reduce the costs and timeliness associated with recruitment subjects for clinical studies.

For More Information

Visit, or contact Jennifer Whitlock, Vice President, at or 443-308-5803.

This press release was issued through eReleases® Press Release Distribution. For more information, visit  

SOURCE Clinical Site Services
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Elsevier / Gold Standard Announces New Drug Class Overviews for Clinical Pharmacology
2. Clinical Phase Ia Trial on MIV-711 Complete and Phase Ib Trial Commences
3. Lightlake Therapeutics Inc. Announces Positive Final Phase II Clinical Trial Results of Binge Eating Disorder Treatment
4. Vitamin D Deficiency Disorders Global Clinical Trials Review, H2, 2012
5. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
6. Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody
7. Infectious Disease Prevalence and New Strains Appearing Each Year Makes a Watertight Case for Clinical Laboratory Testing, Finds Frost & Sullivan
8. Clinical Site Services Chris Trizna Contributing Author in Diana Anderson-Fosters Newest Release Global Issues in Patient Recruitment and Retention
9. ERT Granted Patents on Clinical Trial Participant Compliance
10. Life Technologies to Accelerate Development of Ion Torrent Semiconductor Technology for Proteomic Applications in Research, Applied and Clinical Markets
11. Healthcare Cloud Computing (Clinical, EMR, SaaS, Private, Public, Hybrid) Market - Global Trends, Challenges, Opportunities & Forecasts (2012 - 2017)
Post Your Comments:
(Date:6/27/2016)... GUELPH, ON , June 27, 2016 /PRNewswire/ - BIOREM ... it has been advised by its major shareholders, Clean ... LP, United States based venture ... common shares of Biorem (on a fully diluted, as ... for the disposition of their entire equity holdings in ...
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
Breaking Biology Technology:
(Date:6/22/2016)... BETHESDA, Md. , June 22, 2016  The American ... by Trade Show Executive Magazine as one of ... Summit on May 25-27 at the Bellagio in ... based on the highest percentage of growth in each of ... number of exhibiting companies and number of attendees. The 2015 ...
(Date:6/20/2016)... Securus Technologies, a leading provider of ... safety, investigation, corrections and monitoring announced that after ... secured the final acceptance by all three (3) ... Systems (MAS) installed. Furthermore, Securus will have contracts ... by October, 2016. MAS distinguishes between legitimate wireless ...
(Date:6/9/2016)... , June 9, 2016 ... deploy Teleste,s video security solution to ensure the safety of ... during the major tournament Teleste, an ... systems and services, announced today that its video security solution ... to back up public safety across the country. The ...
Breaking Biology News(10 mins):